Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of Treatment Targets in a Genetic Mouse Model of Voluntary Methamphetamine Drinking
Tamara J. Phillips, John R. K. Mootz, Cheryl Reed
International review of neurobiology (2016), pp. 39-85
Closed Access | Times Cited: 11

Showing 11 citing articles:

Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the Ugly
Karen K. Szumlinski, Kevin D. Lominac, Rianne R. Campbell, et al.
Biological Psychiatry (2016) Vol. 81, Iss. 11, pp. 959-970
Open Access | Times Cited: 65
A Spontaneous Mutation in Taar1 Impacts Methamphetamine-Related Traits Exclusively in DBA/2 Mice from a Single Vendor
Cheryl Reed, Harue Baba, Zhen Zhu, et al.
Frontiers in Pharmacology (2018) Vol. 8
Open Access | Times Cited: 46
Prodrugs and their activation mechanisms for brain drug delivery
Ida Aaberg Lillethorup, Andreas Victor Hemmingsen, Katrine Qvortrup
RSC Medicinal Chemistry (2025)
Open Access
Involvement of endocannabinoid system, inflammation and apoptosis in diabetes induced liver injury: Role of 5-HT3 receptor antagonist
Mohammad Amini, Ehsan Saboory, Bagher Pourheydar, et al.
International Immunopharmacology (2020) Vol. 79, pp. 106158-106158
Closed Access | Times Cited: 19
Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing
Edward J. Modestino, Kenneth Blum, Catherine A. Dennen, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 1946-1946
Open Access | Times Cited: 10
Targeting mGlu5 for Methamphetamine Use Disorder
Johannes Petzold, Karen K. Szumlinski, Edythe D. London
Pharmacology & Therapeutics (2021) Vol. 224, pp. 107831-107831
Closed Access | Times Cited: 12
Depression‐like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake
Shkelzen Shabani, Bryan Schmidt, Bikalpa Ghimire, et al.
Genes Brain & Behavior (2018) Vol. 18, Iss. 3
Open Access | Times Cited: 13
Application of omics-based biomarkers in substance use disorders
Longtao Yang, Lijie Zhang, Huiting Zhang, et al.
Meta-Radiology (2023) Vol. 1, Iss. 1, pp. 100008-100008
Open Access | Times Cited: 3
Voluntary inhalation of methamphetamine: a novel strategy for studying intake non-invasively
Claudia Juárez-Portilla, R. D. Kim, Margaret Robotham, et al.
Psychopharmacology (2016) Vol. 234, Iss. 5, pp. 739-747
Closed Access | Times Cited: 6
The genetic susceptibility analysis of TAAR1 rs8192620 to methamphetamine and heroin abuse and its role in impulsivity
Fei Tang, Longtao Yang, Wenhan Yang, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 274, Iss. 2, pp. 453-459
Closed Access | Times Cited: 2
ERK-Directed Phosphorylation of mGlu5 Gates Methamphetamine Reward and Reinforcement in Mouse
Elissa K. Fultz, Sema G. Quadir, Douglas L. Martin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1473-1473
Open Access | Times Cited: 4
Page 1

Scroll to top